Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
PJP
29
HOLDINGS
72%
ALSO IN XPH
XPH
55
HOLDINGS
42%
ALSO IN PJP
SECTOR DRIFT (PJP minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
VIATRIS, INC. | 2.5% | 2.4% | 2.4% |
|
MERCK & CO. INC. | 5.0% | 2.4% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% | 2.3% | 2.3% |
|
JOHNSON & JOHNSON | 5.1% | 2.2% | 2.2% |
|
SUPERNUS PHARMACEUTICALS INC | 2.8% | 2.2% | 2.2% |
PJP Overweight Relative to XPH
|
ABBVIE INC | 5.3% |
|
AMGEN INC | 4.9% |
|
ABBOTT LABORATORIES | 4.9% |
|
GILEAD SCIENCES INC | 4.7% |
|
UNITED THERAPEUTICS CORP | 3.8% |
|
TRAVERE THERAPEUTICS, INC. | 3.7% |
|
ELI LILLY & CO | 3.4% |
|
PFIZER INC | 3.2% |
|
BIOGEN IDEC INC | 3.0% |
|
JOHNSON & JOHNSON | 2.8% |
PJP Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.6% |
|
EDGEWISE THERAPEUTICS, INC. | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.4% |
|
ELANCO ANIMAL HEALTH, INC. | -2.3% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
ZOETIS INC | -2.1% |
|
AXSOME THERAPEUTICS, INC. | -2.0% |
|
HARROW INC | -2.0% |